Advertise With Us
Subscribe to Newsletter
IB-Logo

[email protected]

  • Markets
  • Business & Finance
    • Forex
    • Stocks
  • Finance
  • Economy
  • Politics
  • Real Estate
  • Crypto
  • AI
  • Health
  • Research
  • Sports
  • More
    • Tech
    • Science
    • Weather
  • Markets
  • Business & Finance
    • Forex
    • Stocks
  • Finance
  • Economy
  • Politics
  • Real Estate
  • Crypto
  • AI
  • Health
  • Research
  • Sports
  • More
    • Tech
    • Science
    • Weather
IB-Logo
Advertise With Us
Subscribe to Newsletter
  • Markets
  • Business & Finance
    • Forex
    • Stocks
  • Finance
  • Economy
  • Politics
  • Real Estate
  • Crypto
  • AI
  • Health
  • Research
  • Sports
  • More
    • Tech
    • Science
    • Weather
  • Markets
  • Business & Finance
    • Forex
    • Stocks
  • Finance
  • Economy
  • Politics
  • Real Estate
  • Crypto
  • AI
  • Health
  • Research
  • Sports
  • More
    • Tech
    • Science
    • Weather

Australian parents are advised to take belladonna as a colic remedy immediately.

Health experts have warned that Australian newborns are becoming sicker than ever after receiving a potentially hazardous colic medication.

admin by admin
June 12, 2024
in Health
0
Australian parents are advised to take belladonna as a colic remedy immediately.

Health experts have warned that Australian newborns are becoming sicker than ever after receiving a potentially hazardous colic medication.

According to NSW Health, a growing number of newborns and infants with suspected anticholinergic syndrome are bringing themselves to physicians and emergency rooms.

Belladonna, a potentially hazardous medication for colic, may aggravate the illness.

Prolonged, inexplicable sobbing fits are characterized by colic.

NSW Health issued a warning, saying that the sickness “may occur after administration of a ‘colic preparation’ purchased online that contains belladonna.”

Even in modest amounts, belladonna is a toxic plant that can be dangerous for infants and young children.

“In neonates, infants, and young children presenting with symptoms of anticholinergic syndrome where ‘colic preparations have been ingested,’ clinicians are advised to have heightened suspicion for belladonna toxicity,” according NSW Health.

Flushed skin, dry skin, dry mouth, dilated pupils, elevated heart rate, urine retention, gastrointestinal problems, elevated fever, anxiety, lethargy, floppiness, poor feeding, and occasionally seizures are some of the signs and symptoms of the syndrome.

Source: dailymail
Tags: Health

RelatedPosts

US Bars Americans in Congo From Immediate Return Home Amid Ebola Outbreak
Health

US Bars Americans in Congo From Immediate Return Home Amid Ebola Outbreak

July 14, 2026
Congo Rebels Establish Independent Ebola Response in Areas Cut Off From Government
Health

Congo Rebels Establish Independent Ebola Response in Areas Cut Off From Government

July 13, 2026
Europe Records More Than 10,000 Excess Deaths During Late-June Heatwave
Health

Europe Records More Than 10,000 Excess Deaths During Late-June Heatwave

July 13, 2026
US Senator Lindsey Graham Dies at 71 After Brief Illness
Health

US Senator Lindsey Graham Dies at 71 After Brief Illness

July 12, 2026
Belfast Hospital That Introduced Public Air Conditioning More Than a Century Ago
Health

Belfast Hospital That Introduced Public Air Conditioning More Than a Century Ago

July 12, 2026
Congo’s Ebola Cases Rise to 1,708 as Death Toll Reaches 580
Health

Congo’s Ebola Cases Rise to 1,708 as Death Toll Reaches 580

July 8, 2026

Facebook

IB-Logo

Latest News & Updates
Premier source for business,
financial news, analysis and insights.

Advertise With Us
  • About Us
  • Contact Us
  • Privacy Policy

© All Rights Reserved 2026 InvestorBytes.

No Result
View All Result
  • About Us
  • Coming Soon
  • Contact Us
  • Main Page
  • Privacy Policy
  • Sample Page

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

Advertise With Us

I don’t want startup news.

Catch up with Startups Weekly

Your weekly dose of startup insights and innovation, delivered right to your inbox.

I don’t want startup news.